Protein Chip Market Size, Share & Trends Analysis Report By Type (Analytical Microarrays, Reverse Phase Protein Microarrays), By Application (Antibody Characterization, Clinical Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Protein Chip Market Size, Share & Trends Analysis Report By Type (Analytical Microarrays, Reverse Phase Protein Microarrays), By Application (Antibody Characterization, Clinical Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Protein Chip Market Growth & Trends

The global protein chip market size is anticipated to reach USD 3.36 billion by 2030 and is projected to grow at a CAGR of 6.88% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the continuous advancements in proteomics research, increasing drug discovery and developments, and ongoing technological advancements are anticipated to increase the demand for protein chips over the forecast period.

The COVID-19 pandemic has had a positive impact on the global market. The COVID-19 outbreak has brought to the forefront the significance of cutting-edge technologies such as protein chips in tackling worldwide health issues. This has spurred innovation, amplified investments, and broadened the use cases of protein chips in disease investigation, diagnostics, and tailored healthcare.

The growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders fuels the demand for advanced tools for disease diagnosis and treatment. Protein chips enable the identification of disease-specific protein biomarkers, aiding in early detection and personalized treatment strategies. For instance, in October 2023, Sengenics Corporation LLC announced the launch of i-Ome Discovery, a precise protein microarray platform for detecting disease-related autoantibodies. It aids academic and clinical research teams in understanding protein-immune system interactions in diseases. Utilizing Sengenics' patented KREX technology, it offers accurate detection of over 1,800 autoantigens relevant to cancer, autoimmune, and neurodegenerative disorders. Thus, anticipated to propel the demand for market growth over the forecast period.

However, protein chip technologies often require expensive equipment, reagents, and specialized expertise, which can pose a barrier to entry for some researchers and laboratories. The high cost of protein chip assays may limit their use in resource-constrained settings or for large-scale studies. Moreover, protein chip technologies involve complex procedures for protein immobilization, assay development, and data analysis. Thus, standardization and reproducibility across different platforms and laboratories is challenging, thus limiting the widespread adoption of protein chips. Thereby anticipated to hamper the market growth.

Protein Chip Market Report Highlights

• Based on type, the analytical microarray segment led the market with the largest revenue share of 54.86% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The use of analytical microarrays enables multiplexing, which allows simultaneous detection and quantification of multiple proteins in a single sample. Thereby boosting the segmental growth over the forecast period
• Based on application, the antibody segment held the market with the largest revenue share of 56.52% in 2023. This is attributed to the increasing demand of antibody-based protein chips due to their wide use in biomarker discovery efforts. On the other hand, the clinical diagnostics segment is expected to grow at the fastest CAGR over the forecast period
• Based on end-use, the academic & research institutes segment led the market with the largest revenue share of 51.56% in 2023, as a wide range of studies in fields such as biology, biochemistry, pharmacology, and medicine, where protein chips play a crucial role in enabling protein analysis, biomarker discovery, drug development, and disease diagnostics
• North America dominated the market with the revenue share of 48.17% in 2023, due to growing cancer incidence, sedentary lifestyle, and rising prevalence of obese population. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period

Please note The report will be delivered in 2-3 business days upon order notification.